Skip to content
  • Tuesday, 29 September 2026
  • 3:41 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Experimental Molecule OLE Identified as Potential Breakthrough in Restoring Microglial Function and Combating Alzheimers Disease
Neuroscience & Brain Research

Experimental Molecule OLE Identified as Potential Breakthrough in Restoring Microglial Function and Combating Alzheimers Disease

Rifan Muazin Jun 19, 2026 0

Researchers at the Institute for Neurosciences in Spain and the École Polytechnique Fédérale de Lausanne in Switzerland have announced the…

Read More
Neuroscience & Brain Research

Unlocking the Mechanism of Lecanemab: VIB-KU Leuven Researchers Identify Fc Fragment as Essential for Microglial Activation in Alzheimer’s Treatment

Rifan Muazin Mar 19, 2026 0

Researchers from the VIB-KU Leuven Center for Brain & Disease Research have published a seminal study in the journal Nature…

Read More
Bioengineered Bone Marrow-on-a-Chip Breakthrough Paves Way for Advanced Drug Screening and Space Medicine ResearchUnlocking the Brains Role in Diabetes Management New Study Reveals Metformin Acts Through Hypothalamic Pathways to Regulate Blood SugarScientists Unveil Proton Shuttle Mechanism for Controlling Triplet Energy Transfer in Quantum Dot SystemsNavigating the Evolution of Oral Solid Dose Pharmaceuticals: CDMOs and Sponsors Face New Demands in Packaging, Sustainability, and Scaling
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must Have
Tolerance Bio Secures Exclusive Global Rights Outside Japan for Tanabe Pharma Anti-IL-33 Monoclonal Antibody TLB-33 in Landmark $560m DealUnprecedented Genetic Study Reveals Explosive Growth Rates and Origins of Chronic Myeloid Leukemia Years Before DiagnosisAs the dream of the autonomous clinical trial dawns, agent supervision is today’s human jobNew Research Identifies Peripheral Immune Pathway as a Critical Driver of Alzheimer’s Disease Neurodegeneration
YOU MAY HAVE MISSED
Pharmaceutical R&D
Tolerance Bio Secures Exclusive Global Rights Outside Japan for Tanabe Pharma Anti-IL-33 Monoclonal Antibody TLB-33 in Landmark $560m Deal
Teuku Ryan Sep 29, 2026
Stem Cell & Regenerative Medicine
Unprecedented Genetic Study Reveals Explosive Growth Rates and Origins of Chronic Myeloid Leukemia Years Before Diagnosis
Dwi Wanna Sep 29, 2026
Laboratory Automation & Robotics
As the dream of the autonomous clinical trial dawns, agent supervision is today’s human job
Lana Keisha Sep 29, 2026
Neuroscience & Brain Research
New Research Identifies Peripheral Immune Pathway as a Critical Driver of Alzheimer’s Disease Neurodegeneration
Rifan Muazin Sep 29, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ